Instituut voor Studie van Schimmel in Menselijke Woningen

Institut pour l'Etude de Moisissure Fongique dans Habitations Humaines

Forschung Insitute für Schimmelpilze in Innenräumen

MYCOLOGICAL  INSTITUTE

for the study of

FUNGAL MOLD IN HUMAN HABITATIONS

VETERINARY MYCOSES - BLASTOMYCOSIS

Veterinary Therapies    Veterinary Aspergillosis     Veterinary Blastomycosis    Veterinary Treatment 1  &  2

Should Dogs be Used to Inspect for Toxic Mold?

DIAGNOSTICS, SAMPLING AND STUDY

       

Blastomycosis (North American Blastomycosis)
Blastomycosis is usually a severe disease, principally of the dog and human (rarely the cat and other animals), caused by the fungus Blastomyces dermatitidis and characterized by an infection that usually begins with the formation of granulomatous nodules in the lungs.
The infection may be confined to the lungs and regional lymph nodes or metastasize to produce the disseminated disease with involvement of the skin, bone and other tissues and organs.
Although there are usually numerous nodules in the lungs, in some instances metastases may come from very limited pulmonary involvement. Occasionally the infection is confined to lesions involving the skin and subcutis. Such infections may persist for months.
Etiology/Source - Blastomyces dermatitidis is a soil-borne, dimorphic fungus. The mycelial phase occurs in nature and the yeast form in vivo.
Distribution/Occurrence - It is probably worldwide in distribution, although the number of cases reported outside of North America is relatively small. The endemic area in the United States includes the middle western, southeastern and Appalachian states. Although single cases are most frequent, multiple cases have been reported in hunting dogs.
Susceptibility - The disease occurs most frequently in dogs; it is rare in cats. Humans are susceptible.
Mode of Infection/Transmission - Inhalation of spores. Infrequently via skin wounds leading to cutaneous lesions. Most often cutaneous lesions are derived from pulmonary infection.
Incubation Period/Course - . The incubation period is variable and may be as long as several months. The course likewise is variable.
Clinical Features - These depend on the stage of the disease. Fever, coughing, dyspnea, anorexia, nasal discharge and progressive loss of condition may be present. Subcutaneous purulent, ulcerative granulomas may also be seen. As the disease spreads, signs reflecting involvement of various organs are observed. Ocular involvement with anterior uveitis and subretinal effusion may be seen. Without treatment the disseminated disease is invariably fatal. Radiographs disclose swollen bronchial lymph nodes and nodular pulmonary lesions.
Diagnosis - 

  • Cryptococcosis, nocardiosis, canine actinomycosis, coccidioidomycosis, histoplasmosis, tuberculosis, chronic granulomatous infections of the skin due to other agents and pneumonia due to other agents should be considered.
  • Chest radiographs may suggest blastomycosis.
  • Material is taken by transtracheal aspiration, transthoracic biopsy and from granulomatous nodules or abscesses involving the skin. An ocular tap can be used if the eye is thought to be involved. Examination of materials in wet mounts for the characteristic thick-walled, single-budding yeasts. Gram-stained smears are examined and culture at room and incubator temperature (37ºC) on appropriate media.
  • The finding of the typical organisms in sections of biopsies or affected lung is highly diagnostic and is the usual means of diagnosis.
  • Serum. Paired samples preferable.
  • Paired samples are preferable. The agar gel immunodiffusion test for antibody indicates a current or recent infection with a reliability of about 90 %.
  • Definitive diagnosis depends on the isolation and identification of B. dermatitidis; however, because it is very time-consuming it is not always carried out.

Treatment - 

  • Itraconazole is the drug of choice; ketoconazole is an alternative. Prolonged treatment, 2 - 3 months, is essential. The recurrence rate may be as high as 20 %.
  • A combination of amphotericin B with ketoconazole or itraconazole is used for dogs with severe infections.
  • In cases confined to the skin and subcutaneous tissue, lesions are removed surgically.

Control - There are no practicable preventive measures.
Public Health Significance - 
Blastomycosis is not considered contagious, but one should avoid contact with infectious material. There are rare reports of humans acquiring the disease while performing necropsies.

Blastomycosis (North American Blastomycosis)
Blastomycosis is usually a severe disease, principally of the dog and human (rarely the cat and other animals), caused by the fungus Blastomyces dermatitidis and characterized by an infection that usually begins with the formation of granulomatous nodules in the lungs.
The infection may be confined to the lungs and regional lymph nodes or metastasize to produce the disseminated disease with involvement of the skin, bone and other tissues and organs.
Although there are usually numerous nodules in the lungs, in some instances metastases may come from very limited pulmonary involvement. Occasionally the infection is confined to lesions involving the skin and subcutis. Such infections may persist for months.
Etiology/Source - Blastomyces dermatitidis is a soil-borne, dimorphic fungus. The mycelial phase occurs in nature and the yeast form in vivo.
Distribution/Occurrence - It is probably worldwide in distribution, although the number of cases reported outside of North America is relatively small. The endemic area in the United States includes the middle western, southeastern and Appalachian states. Although single cases are most frequent, multiple cases have been reported in hunting dogs.
Susceptibility - The disease occurs most frequently in dogs; it is rare in cats. Humans are susceptible.
Mode of Infection/Transmission - Inhalation of spores. Infrequently via skin wounds leading to cutaneous lesions. Most often cutaneous lesions are derived from pulmonary infection.
Incubation Period/Course - . The incubation period is variable and may be as long as several months. The course likewise is variable.
Clinical Features - These depend on the stage of the disease. Fever, coughing, dyspnea, anorexia, nasal discharge and progressive loss of condition may be present. Subcutaneous purulent, ulcerative granulomas may also be seen. As the disease spreads, signs reflecting involvement of various organs are observed. Ocular involvement with anterior uveitis and subretinal effusion may be seen. Without treatment the disseminated disease is invariably fatal. Radiographs disclose swollen bronchial lymph nodes and nodular pulmonary lesions.
Diagnosis - 

  • Cryptococcosis, nocardiosis, canine actinomycosis, coccidioidomycosis, histoplasmosis, tuberculosis, chronic granulomatous infections of the skin due to other agents and pneumonia due to other agents should be considered.
  • Chest radiographs may suggest blastomycosis.
  • Material is taken by transtracheal aspiration, transthoracic biopsy and from granulomatous nodules or abscesses involving the skin. An ocular tap can be used if the eye is thought to be involved. Examination of materials in wet mounts for the characteristic thick-walled, single-budding yeasts. Gram-stained smears are examined and culture at room and incubator temperature (37ºC) on appropriate media.
  • The finding of the typical organisms in sections of biopsies or affected lung is highly diagnostic and is the usual means of diagnosis.
  • Serum. Paired samples preferable.
  • Paired samples are preferable. The agar gel immunodiffusion test for antibody indicates a current or recent infection with a reliability of about 90 %.
  • Definitive diagnosis depends on the isolation and identification of B. dermatitidis; however, because it is very time-consuming it is not always carried out.

Treatment - 

  • Itraconazole is the drug of choice; ketoconazole is an alternative. Prolonged treatment, 2 - 3 months, is essential. The recurrence rate may be as high as 20 %.
  • A combination of amphotericin B with ketoconazole or itraconazole is used for dogs with severe infections.
  • In cases confined to the skin and subcutaneous tissue, lesions are removed surgically.

Control - There are no practicable preventive measures.
Public Health Significance - 
Blastomycosis is not considered contagious, but one should avoid contact with infectious material. There are rare reports of humans acquiring the disease while performing necropsies.

 

                     Canine and Feline Aspergillosis    

Veterinary Therapies    Veterinary Aspergillosis     Veterinary Blastomycosis    Veterinary Treatment 1  &  2